DCF — HOSPITAL CAYETANO COLL & TOSTE
Enterprise Value: $-101.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-101.2M
Enterprise Value
$-31.9M
PV of Cash Flows
$-69.3M
PV of Terminal Value
$-111.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $60.0M | $-6.4M | -11.0% | $-8.9M | $-8.1M |
| Year 2 | $61.8M | $-5.9M | -10.0% | $-8.6M | $-7.1M |
| Year 3 | $63.7M | $-5.5M | -9.0% | $-8.2M | $-6.1M |
| Year 4 | $65.6M | $-5.3M | -8.0% | $-8.1M | $-5.5M |
| Year 5 | $67.6M | $-5.3M | -8.0% | $-8.2M | $-5.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-101.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$58.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.11106963228047204
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5